Jana Obajdin

Analyst Biogeneration Ventures

Jana Obajdin is an Analyst at BioGeneration Ventures (BGV), an early stage fund based in the Netherlands, investing in novel therapeutics across various therapeutic areas. Prior to BGV, Jana was an Associate at venture builder Deep Science Ventures.

Seminars

Wednesday 27th January 2027
Panel Discussion: Where Are Investors Placing Their Bets Across Pain Therapeutics?
10:00 am
  • Which pain targets, technologies and therapeutic approaches are attracting the greatest investment interest today?
  • What data package is required to move a program from scientific promise to an investable opportunity?
  • How are investors assessing technical, clinical and commercial risk in an increasingly competitive pain landscape?
  • Where do investors see the biggest opportunities and unmet needs shaping the next wave of pain innovation?
Headshot of Jana Obajdin, Analyst at Biogeneration Ventures, speaking at the 2nd Non-Opioid Pain Therapeutics Summit